Yung Zip Chemical Ind. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
May 06, 2021 at 01:45 pm EDT
Share
Yung Zip Chemical Ind. Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 107.367 million compared to TWD 104.489 million a year ago. Operating loss was TWD 4.294 million compared to operating Income of TWD 13.818 million a year ago. Net loss was TWD 3.086 million compared to net income of TWD 17.338 million a year ago. Basic loss per share was TWD 0.07 compared to basic earnings per share of TWD 0.41 a year ago.
YUNG ZIP CHEMICAL IND. CO., LTD. is a Taiwan-based company principally engaged in the manufacturing and trading of pharmaceutical ingredient products. Its diclofenac sodium (DCS) is used for the treatment of rheumatoid arthritis, bursitis and inflammation. The acyclovir (ACV) is used for the treatment of herpes virus infections. The miconazole nitrate (MCN) is used for the treatment of yeast infection. The sodium starch glycolate (SSG) is used as disintegrant in pharmaceutical preparation. The Clonidine hydrochloride (CLD) is used for the treatment of hypertension. The Company mainly distributes its products in domestic market and overseas markets, including the United States of America (the USA), Thailand, Indonesia and the Philippines.
YUNG ZIP CHEMICAL IND. CO., LTD. 